| Drug Name: | Rasburicase (134774-45-1) |
|---|---|
| PubChem ID: | |
| SMILES: | |
| InchiKey: | |
| Therapeutic Category: | Antirheumatic Agents, Gout Suppressants |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Hemolytic Anemia | Glucose-6-phosphate 1-dehydrogenase (P11413) | Patients with glucose 6-phosphate dehydrogenase (G6PD) deficiency can precipitate hemolytic anemia [ ADR Type 3 ] | Rasburicase: an innovative new treatment for hyperuricemia associated with tumor lysis syndrome |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category